Drug Shortage Report for KEVZARA
Report ID | 173986 |
Drug Identification Number | 02460548 |
Brand name | KEVZARA |
Common or Proper name | Sarilumab |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SARILUMAB |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | Two pre-filled syringes of 200 mg per carton |
ATC code | L04AC |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-11-07 |
Actual start date | 2022-10-14 |
Estimated end date | 2022-11-30 |
Actual end date | 2022-11-30 |
Shortage status | Resolved |
Updated date | 2022-12-04 |
Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-12-04 | French | Compare |
v9 | 2022-12-04 | English | Compare |
v8 | 2022-11-22 | French | Compare |
v7 | 2022-11-22 | English | Compare |
v6 | 2022-11-17 | French | Compare |
v5 | 2022-11-17 | English | Compare |
v4 | 2022-11-17 | French | Compare |
v3 | 2022-11-17 | English | Compare |
v2 | 2022-11-08 | French | Compare |
v1 | 2022-11-08 | English | Compare |
Showing 1 to 10 of 10